Pediatric healthcare provider Pediatrix Medical Group (NYSE:MD) reported Q1 CY2025 results topping the market’s revenue expectations , but sales fell by 7.4% year on year to $458.4 million. Its ...
Zacks Investment Research on MSN
Here's why Pediatrix Medical can be a smart addition to your portfolio
Pediatrix Medical Group, Inc. MD is well-poised for growth, driven by higher collection activity, improved patient acuity, an ...
Pediatrix Medical Group, Inc. MD is currently trading at a discount compared to the industry average. The stock is currently trading at 9.28X, forward 12-month earnings, which compares to 13.98X for ...
Pediatrix Medical Group, Inc. MD has stepped up its commitment to shareholder returns with a new $250 million share repurchase authorization, underpinned by solid cash generation. Over the past 12 ...
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Pediatrix Medical Group, Inc. (NYSE: MD) will host an investor conference call and webcast on Thursday, February 20, 2025 at 9:00 a.m. ET to discuss results ...
Pediatrix Medical Group, Inc. MD is a physician services provider company that offers a range of services across various specialties, including newborn care, maternal-fetal, radiology, pediatric ...
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Pediatrix Medical Group, Inc. (NYSE:PDX) announced that the Company will change its name to MEDNAX, Inc., to reflect the Company’s development as a national ...
NEW YORK (MarketWatch) -- Pediatrix Medical Group Inc. said Friday that it plans to change its name to Mednax Inc. at the beginning of 2009. At that time, its ticker symbol on the New York Stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback